{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-012368","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2026-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.804038+00:00","generated_at":"2026-05-15T05:59:53.034428+00:00","sec_items":["9.01","8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Integrated BioPharma receives 3-month extension of PNC line of credit to July 14, 2026","bullets":["PNC Bank notified Integrated BioPharma and subsidiary Manhattan Drug on April 14, 2026.","Line of credit expiration extended from April 15, 2026 to July 14, 2026.","Extension subject to PNC's sole discretion to designate a later date via written notice.","No changes to other terms of the promissory note dated April 15, 2025 were disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-012368","json":"https://secwatch.observer/filing/0001437749-26-012368.json","markdown":"https://secwatch.observer/filing/0001437749-26-012368.md","text":"https://secwatch.observer/filing/0001437749-26-012368.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774926012368/0001437749-26-012368-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774926012368/inbp20260415_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:59:53.034428+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}